Search database
Filter
242
Text search: FDC
Featured
Language
Document type
189
20
17
5
4
4
1
1
1
Countries
18
12
10
10
8
8
5
5
5
5
5
4
4
4
4
4
4
3
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
19
16
11
11
7
6
6
4
4
4
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Publication Years
Category
126
39
6
6
3
2
Toolboxes
60
41
14
8
3
2
2
2
1
1
1
The report provides a brief introduction to patents and licences and their effect on the market for antiretroviral (ARV) medicines. It gives an overview of the patent landscape with respect to a select number of ARV medicines in developing countries as of April 2014. The focus is primarily on those ... more
This guide is a resource for physicians and other health care professionals who provide care and treatment to patients with drug-resistant tuberculosis.
National Tuberclosis and Leprosy Programme (NTLP)

Malawi Service Provision Assessement (SPA) 2013-2014

Ministry of Health, Malawi The DHS Program ICF International (2014) C1
Drugs, Diagnostics, Vaccines, Preventive Technologies, Research toward a cure, and immune-based and gene therapies in development
The survey aimed at evaluating the quality of selected antimalarials in six countries of sub-Saharan Africa (Cameroon, Ethiopia, Ghana, Kenya, Nigeria and the United Republic of Tanzania). These countries have been supported by WHO to strengthen their regulatory controls o ... more
The prevalence, availability, and use of antimalarial medicines (AMLs) were studied in six Cambodian provinces along the Thai-Cambodian border. The study was divided into two parts: the first looked at the quality of AMLs available in Pursat, Pailin, Battambang, Bantey Meanchey, Oddar Meanchey, and ... more
3rd editon
Option B+

Improving Access to and Appropriate Use of Medicines for Mental Disorders

Corrado Barbui, Tarun Dua, Kavitha Kolappa et al. World Health Organization and Calouste Gulbenkian Foundation (2017) C_WHO
Revised National TB Control Programme. Annual Status Report
Decree of the Minister of Health of the Republic of Indonesia No. 2500 / MENKES / SK / XII / 2011 on National Essential Medicines List 2011
Regulation of the Minister of Health of the Republic of Indonesia on Impact Reduction for Injecting Narcotics Drug Users NAPZA : Narkotika, Psikotropika dan Zat Adiktif Lainnya (Narcotics, Psychotropic and Other Addictive Substances)
National AIDS and STI Control Program

HIV 2016/2017

C. Hoffmann und J. K. Rockstroh Medizin Fokus Verlag (2016) C2
Sixth edition 2007
The Kenya Essential Medicines List 2019 is an indispensable guide to the medicines recommended for the management of common conditions in Kenya. It is primarily directed at health care providers and medicines supply managers in the public and non-public health sectors. It should be used together wit ... more
NEMLIST | Sixth Edition | February 2016
23rd February 2017, Protea Hotel Thuringerhof, Windhoek | 2017 Namibia ART Guidelines: Summary of New and Old Recommendations
Third Edition: Revised October 2012
“towards quality health and social welfare services”
Annual Report: 2015-2016
UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME
3rd edition.
Third edition 2016

Tuberculosis Care with TB-HIV Co-management

World Health Organization, Intigrated Management of Adolescent and Adult illness (IMAI) World Health Organization, Intigrated Management of Adolescent and Adult illness (IMAI) (2007) C_WHO
WHO/HTM/HIV/2007.01 WHO/HTM/TB/2007.380
First Edition
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO Pharmacovigilance Indicators Handbook 2015.
Ensuring Access to Simple, Safe and Effective First-Line Medicines for Tuberculosis. Accessed in November 2017.
PLOS ONE | DOI:10.1371/journal.pone.0133869 July 28, 2015, p.1-16
Standard Operating Procedures for Implementation of TB Activities at HIV/AIDS Service Delivery Sites
Policy and Manual
NSP Review Engaging with South Africa’s National Strategic Plan for HIV, STIs and TB Edition 7 July – August 2013 A publication of the Treatment Action Campaign and SECTION27 GeneXpert: An imperfect rollout TB in South African prisons: Where to now? Decentralising DR-TB care: How far alon ... more
April 2008
Second Edition, 2012
Version: 24 April 2018
These are integrated National Guidelines 2013 for Prevention and Management of HIV, STIs & Other Blood Borne Infections in accordance with the last guidelines of the World Health Organization (WHO) published in June 2013 and adapted to the Rwandan national context. It thus responds to the need by th ... more
2nd edition. T The Compendium has been developed as a clear and concise instrument to facilitate the understanding and planning of delivery of high-quality care for everybody affected by TB. It incorporates all recent policy guidance from WHO; follows the care pathway of persons with signs or sympt ... more
The toolkit is a collection of assessment tools and checklists that describe the key considerations to be taken into account when transitioning to Option B/B+. The toolkit provides a roadmap to support the planning and implementation of Option B/B+, and to help countries scale up more effective inte ... more
Regulation of the Minister of Health of the Republic of Indonesia Number 5 Year 2014 about the Clinical Practice Guide for Physicians at Primary Health Care Facilities
National Tuberculosis Programme and Senior Paediatricians
This guideline was first developed in 2007 but further updated in 2012 and 2016 to ensure the use of the latest evidence-based international recommendations on childhood TB. The guidelines will fill the gaps in a systematic approach to T ... more
These guidelines aim to guide all health care providers in Myanmar, accommodating the situation of different settings in the context of progressive decentralization of HIV services. Notable changes from the previous edition include:
• diagnosis of HIV
• update on the initiation of ART
... more
The review’s objectives are to review progress in TB control with emphasis on DOTS strategy implementation, summarize the experience, lessons learnt and methods of work and to make recommendations for international donors, technical agencies and the Ministry of Health.
2nd edition. The 2018 Roadmap incorporates an additional critical population: adolescents. Despite making up 1 in 6 of the world’s people, adolescents have been largely overlooked as global momentum to address TB has grown. Spanning the ages of 10–19 years, adolescents are both at risk of TB and ... more
Outstanding child and adolescent TB priorities include the need to: find the missing children with active TB and link them to TB care; prevent TB in children who are in contact with infectious TB cases (through implementation of active contact investigation and provision of preventive treatment); an ... more
The growing challenges for people in low and middle-income countries to access new medicines. Analysis 58
This is an update of a seven-year TB and Leprosy national strategic plan (TBL-NSP), which extends from 2013 to 2020. The update focuses on the plan covering from 2017-20 and is based on the 2017 external mid-term programme review key findings and recommendations; the global and national End TB strat ... more
Meeting report, 25-26 September 2017 Copenhagen, Denmark

WHO mission on ART optimization in Belarus March 30-31, April 1, 2016

M. Ristola; V. Rusovich; J. Lundgren; S. F. Jakobsen World Health Organization (Europe); WHO Collaborating Centre on HIV and Viral Hepatitis (2016) C2
April, 2016

Paediatric - HIV Care and Treatment

USAID; Pata; South to South Zoe life; et al. (2019) C2
Accessed: 08.10.2019

The 2018 optimal formulary and limited-use list for pediatric ARVs

World Health Organization; Unicef; USAID; et al. (2018) C_WHO
Policy Brief